Classes
- ?E0110026A | Faculty of Medicine in Pilsen
- Pulmonary medicineEA0110026 | Faculty of Medicine in Pilsen
- Special Fields of Internal Medicine - pneumologyEA0110026A | Faculty of Medicine in Pilsen
- Possibilities of treatement of pleural disseasesED1P011 | Faculty of Medicine in Pilsen
- Allergies and and airway diseases presented at ERS Annual Congress Amsterdam 2011ED1P101 | Faculty of Medicine in Pilsen
- Parapneumonic fluridothorax, pyothoraxED2P011 | Faculty of Medicine in Pilsen
- Autoimunne Interstitial Lung DiseaseED2P101 | Faculty of Medicine in Pilsen
- HAVEDSZ011 | Faculty of Medicine in Pilsen
- Immunopathology of chronic inflammatory and fibrotic lung and airway diseasesEDSZ101 | Faculty of Medicine in Pilsen
Publications
- New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic2012 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
- Monitoring of the expensive pneumooncological tratment of the advanced non-small cell lung cancer (NSCLC) in the 1st line in the TULUNG registry in the Czech Republic2012 | Third Faculty of Medicine, First Faculty of Medicine
- EGFR mutations in patients with advanced NSCLC2012 | Faculty of Medicine in Pilsen
- Options for testing DNA mutations and DNA methylation assays of circulating cell-free DNA isolated from peripheral blood of NSCLC patients2012 | Publication without faculty affiliation
- Efficiency and safety of pemetrexed and cisplatin therapy in the adenocarcinoma and large cell cancer types of advanced non-small cell lung cancer (NSCLC)2012 | Publication without faculty affiliation
- Clinical Significance of Hypermethylation Status in NSCLC: Evaluation of a 30-Gene Panel in Patients with Advanced Disease2011 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Analysis of advancer NSCLC patients with prolonged progression-free survival after EGFR tyrosine kinase therapy2011 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification2011 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- State-of the art and advances in lung cancer diagnostics and therapy2009 | Central Library of Charles University
- The advances in diagnostic and therapy of lung cancer2008 | Central Library of Charles University
Loading network view...
